AI assistant
Sending…
ARDELYX, INC. — Director's Dealing 2017
Aug 11, 2017
32003_dirs_2017-08-11_d28c2344-4320-428f-b227-2743fe2cdf08.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2017-08-07
Reporting Person: Caldwell Jeremy S (EVP, Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-08-07 | Common Stock | A | 26512 | $0.00 | Acquired | 44497 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-08-09 | Stock Option (Right to Buy) | $4.70 | A | 26512 | Acquired | 2027-08-09 | Common Stock (26512) | Direct |
Footnotes
F1: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof.
F2: The option becomes exercisable as it vests and the shares subject to the option vest with respect to 2/3 of the shares subject thereto on December 31, 2018 and 1/3 of the shares subject thereto on June 1, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
More from ARDELYX, INC.
Proxy Solicitation & Information Statement
2026
May 26
Proxy Solicitation & Information Statement
2026
May 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24